Bond Oracle HER2 IHC System
The Bond Oracle HER2 IHC System is a fully-automated assay to accurately determine HER2 oncoprotein status in breast cancer tissue as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered.
- Accurate - optimized to precisely separate 1+ and 2+ cases gives you excellent FISH concordance, reducing avoidable FISH requests.
- Drive Consistency - standardized protocols for uniform staining, decreased process variation, and consistent results.
- Maximize Efficiency - full automation frees up your skilled staff for other high-value tasks.
- A Complete Solution - integrated ready-to-use reagents, control slides, and advanced automation ensure quality and consistency.
For In Vitro Diagnostics Use
Product Features
Diagnostic Confidence
With treatment decisions dependent on a stained slide, you need confidence that your HER2 staining for breast cancer is consistent and accurate. The Bond Oracle HER2 IHC System gives you the assurance that comes with demonstrated HER2 FISH concordance and complete assay validation.
With the Oracle system, you get the accurate results needed for effective patient management.
Laboratory Efficiency
‘Go Lean’ without increasing resources. The Bond Oracle HER2 IHC System and the fully automated BOND-MAX and BOND-III staining platforms improve the efficiency of your laboratory with increased productivity and walk-away convenience.
Bond Oracle HER2 IHC e-Learning
Increase your knowledge, score real cases and test yourself. The interactive e-Learning course assists histologists and pathologists considering HER2 testing by covering all aspects of the Bond Oracle HER2 System.
Brochure
Oracle HER2 Breast Brochure FR
Size: 542.03 KB,
Type: pdf
Oracle HER2 Brochure EN
Size: 2.02 MB,
Type: pdf
Oracle HER2 Brochure ES
Size: 1.92 MB,
Type: pdf
Oracle HER2 Brochure IT
Size: 1.93 MB,
Type: pdf
Oracle HER2 Brochure NL
Size: 1.92 MB,
Type: pdf
Oracle HER2 Brochure PT
Size: 1.92 MB,
Type: pdf
Oracle HER2 Interpretation Guide (Breast)
Size: 1.34 MB,
Type: pdf
Oracle HER2 Interpretation Guide FR
Size: 1.25 MB,
Type: pdf
Oracle HER2 Scoring Guide (Breast)
Size: 729.56 KB,
Type: pdf
Oracle HER2 Scoring Guide ES
Size: 636.46 KB,
Type: pdf
Oracle HER2 Scoring Guide FR
Size: 180.47 KB,
Type: pdf
Oracle HER2 Scoring Guide IT
Size: 650.92 KB,
Type: pdf
Oracle HER2 Scoring Guide NL
Size: 652.1 KB,
Type: pdf
Oracle HER2 Scoring Guide PT
Size: 653.57 KB,
Type: pdf
Material Safety Data Sheets
TA9145 MSDS BG 08JAN2021
Size: 1.09 MB,
Type: pdf
TA9145 MSDS DA 08JAN2021
Size: 849.26 KB,
Type: pdf
TA9145 MSDS DE 08JAN2021
Size: 947.27 KB,
Type: pdf
TA9145 MSDS EL 08JAN2021
Size: 1.01 MB,
Type: pdf
TA9145 MSDS EN 08JAN2021
Size: 926.33 KB,
Type: pdf
TA9145 MSDS ES 08JAN2021
Size: 813.18 KB,
Type: pdf
TA9145 MSDS FR 08JAN2021
Size: 942.3 KB,
Type: pdf
TA9145 MSDS HU 08JAN2021
Size: 1.01 MB,
Type: pdf
TA9145 MSDS IT 08JAN2021
Size: 950.16 KB,
Type: pdf
TA9145 MSDS NL 08JAN2021
Size: 863.88 KB,
Type: pdf
TA9145 MSDS NO 08JAN2021
Size: 842.56 KB,
Type: pdf
TA9145 MSDS PL 08JAN2021
Size: 1.1 MB,
Type: pdf
TA9145 MSDS PT 08JAN2021
Size: 859.31 KB,
Type: pdf
TA9145 MSDS RO 08JAN2021
Size: 1021.53 KB,
Type: pdf
TA9145 MSDS RU 08JAN2021
Size: 1022.6 KB,
Type: pdf
TA9145 MSDS SL 08JAN2021
Size: 1.05 MB,
Type: pdf
TA9145 MSDS SV 08JAN2021
Size: 839.11 KB,
Type: pdf
TA9145 MSDS TR 08JAN2021
Size: 1 MB,
Type: pdf
Newsletters
reSOLUTION PandD Special-May08
Size: 724.29 KB,
Type: pdf
reSOLUTION P&D 05
Size: 3.01 MB,
Type: pdf
Press Releases
080602 PR HER2 IHC en
Size: 53.5 KB,
Type: doc
